Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuechen Luo

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Blood|May 7, 2025
Targeting CD38 with Daratumumab for Platelet Transfusion Refractoriness in Aplastic AnemiaZhen Gao, Hong Pan, Lele Zhang, et al.
Nature Communications|June 17, 2017
Lkb1 maintains T<sub>reg</sub> cell lineage identityDi Wu, Yuechen Luo, Wei Guo, et al.
Nature Communications|December 15, 2018
Control of T<sub>reg</sub> cell homeostasis and immune equilibrium by Lkb1 in dendritic cellsSong Chen, Lijun Fang, Wei Guo, et al.
Nature Communications|June 24, 2021
Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human T<sub>reg</sub> compartmentYuechen Luo, Changlu Xu, Bing Wang, et al.
Cellular & Molecular Immunology|October 31, 2019
Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantationXiuhua Su, Qianqian Wang, Wei Guo, et al.
The Lancet. Oncology|October 20, 2023
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 studyJing Pan, Kaiting Tang, Yuechen Luo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2024
Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trialLiping Zhao, Chuo Li, Shiyu Zuo, et al.
The New England Journal of Medicine|January 14, 2026
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic AnemiaRuonan Li, Hong Pan, Lele Zhang, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Blood|May 7, 2025
Targeting CD38 with Daratumumab for Platelet Transfusion Refractoriness in Aplastic AnemiaZhen Gao, Hong Pan, Lele Zhang, et al.
Nature Communications|June 17, 2017
Lkb1 maintains T<sub>reg</sub> cell lineage identityDi Wu, Yuechen Luo, Wei Guo, et al.
Nature Communications|December 15, 2018
Control of T<sub>reg</sub> cell homeostasis and immune equilibrium by Lkb1 in dendritic cellsSong Chen, Lijun Fang, Wei Guo, et al.
Nature Communications|June 24, 2021
Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human T<sub>reg</sub> compartmentYuechen Luo, Changlu Xu, Bing Wang, et al.
Cellular & Molecular Immunology|October 31, 2019
Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantationXiuhua Su, Qianqian Wang, Wei Guo, et al.
The Lancet. Oncology|October 20, 2023
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 studyJing Pan, Kaiting Tang, Yuechen Luo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2024
Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trialLiping Zhao, Chuo Li, Shiyu Zuo, et al.
The New England Journal of Medicine|January 14, 2026
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic AnemiaRuonan Li, Hong Pan, Lele Zhang, et al.
Pageof 3